IMABGEN Project, an innovative platform in immunotherapies

December 16, 2021

The IMABGEN Platform project, an innovative service for the generation of therapeutic antibodies carried by BIOTEM, CALIXAR and the CNRS / Université Claude Bernard Lyon 1, is one of the laureates of the ‘‘R&D Booster’’ 2021 program driven by the Region Auvergne-Rhône-Alpes.

Read the article

Conformational antibody development

Vaccine development

Ligand high-throughput screening

Structure-based drug discovery

Immunoassays

Deorphanization projects

Identification of relevant targets

Expression of full-length membrane proteins

Functional isolation and stabilization of targets

Conformational antibody development

Vaccine development

High-throughput ligand screening

Structure-based drug discovery

Immunoassays

Deorphanization projects

Identification of relevant targets

Expression of full-length membrane proteins

Functional isolation and stabilization of targets

Secure and boost
your discovery programs.

Starting from native material or recombinant systems, we succeed with all types of membrane proteins: GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.